The last two decades have witnessed the steady growth of the protein drug market. As original recombinant products come off patent, generics/ biosimilars are also beginning to be manufactured. The ...

CAMBRIDGE, England--(BUSINESS WIRE)--Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia™ assay portfolio with the ...

The accurate determination of protein concentration is a foundational requirement in molecular biology, proteomics, and clinical diagnostics. Choosing the most appropriate protein quantification ...

Reliable protein quantification is essential across bioprocess development workflows, from early-stage screening through to ...

Nomic Publishes Foundational Protein Quantification Technology in Nature Methods The company highlights how its technology powers large-scale proteomic perturbation studies, unveiling Perturb-PBMC, a ...

Measure His-tag protein expression directly from crude lysates with consistent, reproducible protein quantification across ...

As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...

Illumina, Inc. ILMN recently announced the launch of Illumina Protein Prep, an assay designed to deliver superior performance for next-generation sequencing (NGS)-based proteomics discovery at scale.

Abselion, announced the launch of its Protein G Total Antibody Quantification Kit. The new kit is designed for use with the company’s Amperia™ benchtop platform and complements the existing Protein ...

By expanding access to validated VEGF ELISA kits, Boster Bio aims to support more consistent data generation in serum-based ...